Mira Pharmaceuticals Files 8-K
Ticker: MIRA · Form: 8-K · Filed: Apr 1, 2025 · CIK: 1904286
| Field | Detail |
|---|---|
| Company | Mira Pharmaceuticals, Inc. (MIRA) |
| Form Type | 8-K |
| Filed Date | Apr 1, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-event, filing
TL;DR
Mira Pharma filed an 8-K, but details are scarce.
AI Summary
Mira Pharmaceuticals, Inc. filed an 8-K on April 1, 2025, reporting an "Other Event." The filing does not contain specific details about the event itself, but it confirms the company's name, incorporation in Florida, and principal executive offices in Miami. The company was formerly known as Mira1a Therapeutics, Inc., with a name change effective January 12, 2022.
Why It Matters
This 8-K filing indicates a corporate event has occurred for Mira Pharmaceuticals, Inc., requiring disclosure to the SEC, though the specific nature of the event is not detailed in the provided text.
Risk Assessment
Risk Level: low — The filing is a standard corporate disclosure without immediate financial or operational news, making the immediate risk level low.
Key Players & Entities
- MIRA PHARMACEUTICALS, INC. (company) — Registrant
- Mira1a Therapeutics, Inc. (company) — Former company name
- April 1, 2025 (date) — Date of report
- January 12, 2022 (date) — Date of former name change
- Miami, Florida (location) — Principal executive offices
FAQ
What specific event is reported in this 8-K filing by Mira Pharmaceuticals, Inc.?
The provided text of the 8-K filing does not specify the nature of the 'Other Event' being reported.
When was the report filed with the SEC?
The report was filed as of April 1, 2025.
What was Mira Pharmaceuticals, Inc. formerly known as?
Mira Pharmaceuticals, Inc. was formerly known as Mira1a Therapeutics, Inc.
When did the company change its name from Mira1a Therapeutics, Inc.?
The date of the name change was January 12, 2022.
Where are Mira Pharmaceuticals, Inc.'s principal executive offices located?
The principal executive offices are located at 1200 Brickell Avenue, Suite 1950 #1183, Miami, Florida 33131.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 1, 2025 regarding MIRA PHARMACEUTICALS, INC. (MIRA).